PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetes
Year: 2012
Type: article
Source: Bioorganic & Medicinal Chemistry
Institutions: IRBM, Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Endocrine and Autonomic Systems
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2012452245
